Target intelligence / Profile preview

Protospacer-adjacent motif (PAM) (PAM)

Target
PAM
Molecular classification
Nucleic acid, Other
01

Overview

The genomic DNA protospacer adjacent to a protospacer-adjacent motif (PAM) is the fundamental recognition site for CRISPR-Cas genome editing technologies. The PAM is a short, conserved DNA sequence (e.g., 5'-NGG-3' for SpCas9) located immediately adjacent to the target DNA sequence, known as the protospacer (Mojica et al., 2009, Microbiology). This motif is essential for the Cas nuclease to distinguish between 'self' DNA (the CRISPR array in the bacterial genome) and 'non-self' DNA (invading viral or plasmid DNA), as the PAM is absent in the host's own CRISPR locus (Sternberg et al., 2014, Nature). In a therapeutic context, the Cas-gRNA complex utilizes the PAM as an anchor to initiate DNA unwinding and subsequent base pairing with the protospacer, enabling precise genomic modifications such as gene disruption or correction (Doudna & Charpentier, 2014, Science). While highly effective for treating genetic disorders like sickle cell disease, the requirement for a specific PAM limits the targetable range of the genome, and unintended binding to 'PAM-like' sequences can lead to deleterious off-target effects (Jinek et al., 2012, Science). Consequently, engineering Cas variants with expanded PAM compatibility or higher fidelity is a major focus of current biotechnological research.

Other names
PAM sequenceProtospacerCRISPR target siteTarget DNA motif
02

Mechanism of action

The CRISPR-Cas complex (e.g., Cas9-gRNA) scans genomic DNA for a specific Protospacer-adjacent motif (PAM). Upon PAM recognition, the Cas protein facilitates DNA melting, allowing the guide RNA to hybridize with the complementary protospacer sequence, which leads to site-specific double-strand breaks or base editing (Jinek et al., 2012, Science; Sternberg et al., 2014, Nature).

03

Biological functions

Adaptive immunityOther
04

Disease associations

Genetic diseaseOther
05

Safety considerations

Off-target effectsGenotoxicityImmunogenicity of bacterial Cas proteinsChromosomal rearrangementsP53-mediated DNA damage response
06

Interacting drugs

Exagamglogene autotemcel

2 more in the full profile.

07

Biomarkers

On-target editing efficiencyOff-target mutation frequencyIndel formation rate

Beyond the preview

Go deeper on Protospacer-adjacent motif (PAM) (PAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protospacer-adjacent motif (PAM) (PAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call